Clinical Trial

BosSTENT Implantation to Treat Pulse-Synchronous Tinnitus

Study acronym: B-SILENT
Recruiting
View on ClinicalTrials.gov →
Summary
This study is evaluating the safety and clinical performance of the BosSTENT, a new stent designed specifically for treating pulse-synchronous tinnitus due to venous sinus stenosis. The study will evaluate the long-term safety of the BosSTENT as well as its impact on the severity of pulse-synchronous tinnitus.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-14; most recent amendment 2026-04-10.
Status change: Not Yet Recruiting → Recruiting 2026-04-10
Status change: Withheld → Not Yet Recruiting 2025-09-25
Trial Details
NCT Number NCT07070089
Lead Sponsor Sonorous NV, Inc
Conditions Pulsatile Tinnitus, Venous Sinus Stenosis
Enrollment 90 participants
Start Date 2026-02-01
Primary Completion 2027-07 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-04-15